NEW POSSIBILITIES FOR THE TREATMENT OF DRY EYE SYNDROME IN AN INTERNIST’S PRACTICE
DOI: https://doi.org/10.29296/25877305-2019-02-05
Issue:
2
Year:
2019
One of the common causes of worse quality of life and disability in the active population of almost all ages is dry eye syndrome (DES), a set of corneal and conjunctival changes caused by systematic tear film destabilization. In some cases DES causes severe changes in the cornea - its irreversible opacities, ulcerations, and even perforation. DES treatment and prevention with drugs that moisturize the ocular surface is the therapy of choice. There are a significant amount of tear substitutes on the market, but when making a choice, it is important to remember about the need for long-term treatment of the ocular surface and the safety of the components of an eye medication.
Keywords:
ophthalmology
endocrinology
therapy
dry eye syndrome
thyroid disease
drugs
tear substitutes
References:
- Population Ageing. United Nations publication 2017; Sales No. E.06.XIII.2. UnitedNations (2017).World Population Prospects: the 2017 Revision.
- Brzheskij V.V., Somov E.E. Rogovichno-kon'junktival'nyj kseroz / SPb, 2003; 119 s. [Brzheskii V.V., Somov E.E. Rogovichno-kon»yunktival'nyi kseroz / SPb, 2003; 119 p. (in Russ.)].
- Gayton J. Etiology, prevalence, and treatment of dry eye disease // Clin. Ophthalmol. – 2009; 3: 405–12.
- Sheppard J. Guidelines for the treatment of chronic dry eye disease // Manag. Care. – 2003; 12 (Suppl. 12): 20–5.
- Oftal'mologija. Natsional'noe rukovodstvo. Pod. red. Avetisova S.E., Egorova E.A., Moshetovoj L.K., Neroeva V.V., Tahchidi H.P. / M.: GEOTAR-Media, 2018; 944 c. [Oftal'mologiya. Natsional'noe rukovodstvo. Pod. red. Avetisova S.E., Egorova E.A., Moshetovoi L.K., Neroeva V.V., Takhchidi Kh.P. / M.: GEOTAR-Media, 2018; 944 (in Russ.)].
- Somov E.E., Brzheskij V.V. Kratkoe rukovodstvo po obsledovaniju i lecheniju bol'nyh s sindromom «suhogo glaza» / SPb: Vel', 2003; 32 s. [Somov E.E., Brzheskii V.V. Kratkoe rukovodstvo po obsledovaniyu i lecheniyu bol'nykh s sindromom «sukhogo glaza» / SPb: Vel', 2003; 32 s. (in Russ.)].
- Dedov I.I., Mel'nichenko G.A., Sviridenko N.Ju. i dr. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju endokrinnoj oftal'mopatii pri autoimmunnoj patologii schitovidnoj zhelezy // Problemy endokrinologii. – 2015; 61 (1): 61–74 [Dedov I.I., Melnichenko G.A., Sviridenko N.Yu. et al. Federal clinical recommendations on diagnostics and treatment of endocrine ophthalmopathy associated with autoimmune thyroid pathology // Problems of endocrinology. – 2015; 61 (1): 61–74 (in Russ.)]. DOI: 10.14341/probl201561161-74.
- Brovkina A.F., Moslehi Sh.F. Sindrom suhogo glaza u bol'nyh endokrinnoj oftal'mopatiej // Oftal'mol. ved. – 2008; 1 (4): 29–34 [Brovkina A.F., Moslekhi Sh.Kh. Sindrom sukhogo glaza u bol'nykh endokrinnoi oftal'mopatiei // Oftal'mol. Ved. – 2008; 1 (4): 29–34 (in Russ.)].
- Teping Ch., Bischoff G. Treatment of sicca syndrome – effective and well-tolerated also with contact lenses // Drug Report: Hyaluronic acid. – 2010; 4 (2): 15.
- HILOPARIN–KOMOD® Rastvor uvlazhnjajuschij oftal'mologicheskij. Instruktsija po primeneniju [HILOPARIN–SOMOD® Rastvor uvlazhnyayushchii oftal'mologicheskii. Instruktsiya po primeneniyu (in Russ.)].
- Teping C., Wiedemann B. Das Comod' System. Ein konservierungsmittelfreies Mehrdosenbehaltnis fur Augentropfen // Klin. Monatsbl. Augenheilkd. – 1994; 205: 210–7.
- Mousavi S., Moradi M., Khorshidahmad T. et al. Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review // Adv. Pharmacol. Sci. – 2015; 2015: Article ID 507151.
- Knorr M., Wunderlich K., Steuhl K. et al. Wirkung von Heparin und Ascorbinsure auf das Wachstumsverhaltenkultivierter Hornhautepithelzellendes Kaninchens // Der. Ophthalmologe. – 1996; 93: 275–8.
- Egorov E.A., Romanova T.B., Kats D.V. i dr. Primenenie rastvora Hiloparin-Komod® v oftal'mologicheskoj praktike (pilotnoe issledovanie) // RMZh. Klinicheskaja oftal'mologija. – 2014; 4: 207–12 [Egorov E.A., Romanova T.B., Katz D.V. et al. Application of the solution HYLO-PARIN – COMOD® in ophthalmological practice (pilot study) // RMJ. Clinical ophthalmology. – 2014; 4: 207–12 (in Russ.)].
- Tkachenko N.V., Astahov S.Ju. Opyt primenenija «Hiloparina» v klinicheskoj praktike // Oftal'mol. ved. – 2014; 7 (4): 53–62 [Tkachenko N.V., Astakhov S.Yu. The experience of “Hyloparin” use in clinical practice // Ophthalmology journal (Oftal’mol. ved.). – 2014; 7 (4): 53–62 (in Russ.)].
- Egorov E.A., Romanova T.B., Oganezova Zh.G. i dr. Rezul'taty primenenija geparin-soderzhaschego smazyvajuschego sredstva v lechenii sindroma «suhogo glaza» // RMZh. Klinicheskaja oftal'mologija. – 2017; 3: 135–40 [Egorov E.A., Romanova T.B., Oganezova J.G. et al. Results of application of heparin-containing lubricant in the treatment of dry eye syndrome // RMJ. Clinical ophthalmology. – 2017; 3: 135–40. (in Russ.)].